Premium
Anabolic effects of a non‐myotoxic dose of the β 2 ‐adrenergic receptor agonist clenbuterol on rat plantaris muscle
Author(s) -
Burniston Jatin G.,
McLean Lynn,
Bey Robert J.,
Goldspink David F.
Publication year - 2007
Publication title -
muscle and nerve
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.025
H-Index - 145
eISSN - 1097-4598
pISSN - 0148-639X
DOI - 10.1002/mus.20684
Subject(s) - clenbuterol , medicine , endocrinology , myocyte , muscle hypertrophy , myosin , phosphoglycerate mutase , biology , chemistry , glycolysis , biochemistry , metabolism
Previous investigations of the effects of clenbuterol have used suprapharmacological doses that induce myocyte death, alter muscle phenotype, and do not approximate the proposed therapeutic dose for humans. Recently, we reported that smaller doses of clenbuterol induce muscle growth without causing myocyte death. In the present study we used histochemical and proteomic techniques to investigate the molecular effects of this dose. Male Wistar rats ( n = 6, per group) were infused with saline or 10 μg/kg/day clenbuterol via subcutaneously implanted osmotic pumps. After 14 days the animals' plantaris muscles were isolated for histochemical and proteomic analyses. Clenbuterol induced significant muscle growth with concomitant protein accretion and preferential hypertrophy of fast oxidative glycolytic fibers. Clenbuterol reduced the optical density of mitochondrial staining in fast fibers by 20% and the glycogen content of the muscle by 30%. Differential analysis of two‐dimensional gels showed that heat shock protein 72 and β‐enolase increased, whereas aldolase A, phosphogylcerate mutase, and adenylate kinase decreased. Only heat shock protein 72 has previously been investigated in clenbuterol‐treated muscles. The clenbuterol‐induced increase in muscle growth was concomitant with qualitative changes in the muscle's proteome that need to be considered when proposing therapeutic uses for this agent. Muscle Nerve, 2006